Efficacy and Safety of Acoramidis (AG10) in Subjects with Transthyretin Amyloid Polyneurophathy (ATTRibute-PN)

Clinical trial NCT04882735 · WITHDRAWN

Trial details

NCT number: NCT04882735
Sponsor: Eidos Therapeutics, a BridgeBio company
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy

Start date: 2021-09-08
Primary completion: 2026-09-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.